Medical Device Innovation in the Era of the Affordable Care Act
The End of Sexy
Expert InsightsPublished Feb 8, 2016
In this Perspective, the authors explore why medical device innovation has traditionally been geared so thoroughly toward improving performance, with little regard to cost. They argue that the changing incentives in the health care sector and the move to value-based payment models, accelerated by the implementation of the Affordable Care Act, will force device manufacturers to redirect investments from the spectacular toward the prudent, which they dub "the end of sexy." The authors explore consequences for manufacturers, investors, and policymakers.
Topics
Document Details
- Copyright: RAND Corporation
- Availability: Web-Only
- Year: 2016
- Pages: 12
- DOI: https://doi.org/10.7249/PE176
- Document Number: PE-176-RC
Citation
RAND Style Manual
Chicago Manual of Style
Mattke, Soeren, Harry H. Liu, and Patrick Orr, Medical Device Innovation in the Era of the Affordable Care Act: The End of Sexy, RAND Corporation, PE-176-RC, February 2016. As of September 24, 2024: https://www.rand.org/pubs/perspectives/PE176.html
Mattke, Soeren, Harry H. Liu, and Patrick Orr, Medical Device Innovation in the Era of the Affordable Care Act: The End of Sexy. Santa Monica, CA: RAND Corporation, 2016. https://www.rand.org/pubs/perspectives/PE176.html.
This research in the public interest was was funded by philanthropic contributions from RAND supporters and income from operations and was conducted within RAND Health.
This publication is part of the RAND expert insights series. The expert insights series presents perspectives on timely policy issues.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.